Abstract
We developed a thyroid testing panel to assess endocrine disrupting chemicals (EDCs) capacities to bind either the thyroid receptor β (TRβ) or the thyroid hormones transporter transthyretin (TTR). We first stably transfected a human U2OS cell line with TRβ and a luciferase reporter construct to develop the TRβ CALUX® reporter gene assay to assess chemicals’ potential to interact with TRβ. Secondly, we combined a TTR-binding assay with the TRβ CALUX (TTR-TRβ CALUX) and optimized the system to evaluate the competitive properties of EDCs towards T4 for TTR binding. Both systems were evaluated with a range of known thyroid-disrupting compounds. The agonistic/antagonistic TRβ CALUX successfully predicted 9/9 and 9/12 test compounds, respectively. The TTR-TRβ CALUX predicted 9/9 compounds and demonstrated competitive activities when analyzing waste water samples. We concluded that the proposed test battery is a promising screening method able to efficiently generate data on thyroid hormone interferences by chemicals.
Original language | English |
---|---|
Pages (from-to) | 432-444 |
Number of pages | 13 |
Journal | Reproductive Toxicology |
Volume | 96 |
Early online date | 8 May 2019 |
DOIs | |
Publication status | Published - Sept 2020 |
Funding
This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 722634 .
Funders | Funder number |
---|---|
European Union's Horizon 2020 research and innovation program | |
European Union’s Horizon 2020 research and innovation program | |
Marie Sklodowska-Curie | 722634 |
Keywords
- Bioassay
- CALUX
- Endocrine disruption
- Thyroid hormones
- TTR binding potency
- Water extract